Epidermal growth factor receptor as a therapeutic target in head and neck cancer
- 1 July 2002
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 12 (3), 11-20
- https://doi.org/10.1053/srao.2002.34864
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- THE WILLET F. WHITMORE, JR., LECTURESHIP: BLOCKADE OF EPIDERMAL GROWTH FACTOR RECEPTORS AS ANTICANCER THERAPYJournal of Urology, 2001
- The EGF receptor family as targets for cancer therapyOncogene, 2000
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalJNCI Journal of the National Cancer Institute, 1998
- Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neckRadiation Oncology Investigations, 1997
- Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptorMolecular and Cellular Endocrinology, 1995
- Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.Journal of Clinical Oncology, 1993
- Expression of resistance factors (P-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomasCancer, 1993
- Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer. Relation to cisplatin sensitivityCancer, 1993
- Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomasHead & Neck, 1991
- Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1989